Correction: Clinical implications of DNA methylation-based integrated classification of histologically defined grade 2 meningiomas.

Autor: Ehret F; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Radiation Oncology, Berlin, Germany. felix.ehret@charite.de.; Charité - Universitätsmedizin Berlin, Germany; German Cancer Consortium (DKTK), partner site Berlin and German Cancer Research Center (DKFZ), Heidelberg, Germany. felix.ehret@charite.de., Perez E; Charité - Universitätsmedizin Berlin, Germany; German Cancer Consortium (DKTK), partner site Berlin and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neuropathology, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin School of Integrative Oncology (BSIO), Berlin, Germany., Teichmann D; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neuropathology, Berlin, Germany., Meier S; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neuropathology, Berlin, Germany., Geiler C; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neuropathology, Berlin, Germany., Zeus C; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neuropathology, Berlin, Germany., Franke H; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Radiation Oncology, Berlin, Germany., Roohani S; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Radiation Oncology, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Germany; German Cancer Consortium (DKTK), partner site Berlin and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Junior Clinician Scientist Program, Berlin, Germany., Wasilewski D; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neurosurgery, Berlin, Germany., Onken J; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neurosurgery, Berlin, Germany., Vajkoczy P; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neurosurgery, Berlin, Germany., Schweizer L; Institute of Neurology (Edinger Institute), University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt Am Main, Germany., Kaul D; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Radiation Oncology, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Germany; German Cancer Consortium (DKTK), partner site Berlin and German Cancer Research Center (DKFZ), Heidelberg, Germany., Capper D; Charité - Universitätsmedizin Berlin, Germany; German Cancer Consortium (DKTK), partner site Berlin and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neuropathology, Berlin, Germany.

Publikováno v: Acta neuropathologica communications [Acta Neuropathol Commun] 2024 Jun 15; Vol. 12 (1), pp. 96. Date of Electronic Publication: 2024 Jun 15.

TERT promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymoma.

Autor: Thomas C; Institute of Neuropathology, University Hospital Münster, Münster, Germany., Thierfelder F; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany., Träger M; Department of Radiation Oncology and Radiotherapy, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Augustenburger Platz 1, 13353, Berlin, Germany., Soschinski P; Institute of Neuropathology, University Hospital Münster, Münster, Germany., Müther M; Department of Neurosurgery, University Hospital Münster, Münster, Germany., Edelmann D; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany., Förster A; Department of Neuropathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Germany., Geiler C; Department of Neuropathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Germany., Kim HY; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany., Filipski K; Neurological Institute (Edinger Institute), Goethe University, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, German Cancer Research Center (DKFZ), Heidelberg, Germany., Harter PN; Neurological Institute (Edinger Institute), Goethe University, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany., Schittenhelm J; Department of Neuropathology, Institute of Pathology and Neuropathology, University of Tübingen, Tübingen, Germany., Eckert F; Department of Radiooncology, University Hospital Tübingen, Tübingen, Germany., Ntoulias G; Department of Neurosurgery, Vivantes Klinikum Neukölln, Berlin, Germany., May SA; Department of Neurosurgery, Klinikum Chemnitz, Chemnitz, Germany., Stummer W; Department of Neurosurgery, University Hospital Münster, Münster, Germany., Onken J; Department of Neurosurgery, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Germany., Vajkoczy P; Department of Neurosurgery, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Germany., Schüller U; Department of Neuropathology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.; Research Institute Children's Cancer Center Hamburg, Hamburg, Germany.; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Heppner FL; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Neuropathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Germany.; Cluster of Excellence, NeuroCure, Charitéplatz 1, 10117, Berlin, Germany.; German Center for Neurodegenerative Diseases (DZNE) Berlin, 10117, Berlin, Germany., Capper D; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Neuropathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Germany., Koch A; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Neuropathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Germany., Kaul D; Department of Radiation Oncology and Radiotherapy, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Augustenburger Platz 1, 13353, Berlin, Germany., Paulus W; Institute of Neuropathology, University Hospital Münster, Münster, Germany., Hasselblatt M; Institute of Neuropathology, University Hospital Münster, Münster, Germany., Schweizer L; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany. leonille.schweizer@charite.de.; Department of Neuropathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Germany. leonille.schweizer@charite.de.

Publikováno v: Acta neuropathologica [Acta Neuropathol] 2021 Jun; Vol. 141 (6), pp. 959-970. Date of Electronic Publication: 2021 Mar 23.

Wake vortex investigations with PIV in the catapult B20 at ONERA Lille

Autor: Schröder, Andreas, Vollmers, Heinrich, Heider, André, Christou, Konstantin, Mattner, Hartmut, Gilliot, Anne, Geiler, C., Fatien, C., Monnier, J.-C., Coton, P., Lozier, J.-F., Brunel, E.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1640::efa2e98cb616aa0b52a13145bbf0d679
https://elib.dlr.de/21981/

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Genetically Engineered In Vitro Erythropoiesis.

Autor: Geiler C; Department of Basic Science Research, Cellologi, LLC, California, USA.; Santa Barbara Cottage Hospital, Santa Barbara, California, USA., Andrade I; Department of Basic Science Research, Cellologi, LLC, California, USA., Clayton A; Department of Basic Science Research, Cellologi, LLC, California, USA., Greenwald D; Department of Basic Science Research, Cellologi, LLC, California, USA.; Santa Barbara Cottage Hospital, Santa Barbara, California, USA.

Publikováno v: International journal of stem cells [Int J Stem Cells] 2016 May 30; Vol. 9 (1), pp. 53-9.